Serum and ectopic endometrium from women with endometriosis modulate macrophage M1/M2 polarization via the Smad2/Smad3 pathway

Journal of Immunology Research

Volumn 2018, Issue , 2018, Pages

  Nie, Mei Fang ^a   Xie, Qi ^a   Wu, Ya Hong ^a   He, Hua ^a   Zou, Lu Jie ^a   She, Xiao Ling ^a   Wu, Xian Qing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CD163 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; SMAD2 PROTEIN; SMAD3 PROTEIN; CYTOKINE; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; PERITONEAL FLUID; PHENOTYPE; STROMA CELL; THP-1 CELL LINE; UPREGULATION; CELL DIFFERENTIATION; CHORISTOMA; COCULTURE; ENDOMETRIUM; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; PHYSIOLOGY; SERUM; SIGNAL TRANSDUCTION;

ADULT; CELL DIFFERENTIATION; CHORISTOMA; COCULTURE TECHNIQUES; CYTOKINES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOMODULATION; MACROPHAGES; SERUM; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; STROMAL CELLS; THP-1 CELLS;

EID: 85054093433     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2018/6285813     Document Type: Article

References (30)

1. C. Mehedintu, M. N. Plotogea, S. Ionescu, and M. Antonovici, “Endometriosis still a challenge,” Journal of Medicine and Life, vol. 7, no. 3, pp. 349–357, 2014.
2. P. Vercellini, P. Vigano, E. Somigliana, and L. Fedele, “Endometriosis: pathogenesis and treatment,” Nature Reviews. Endocrinology, vol. 10, no. 5, pp. 261–275, 2014.
3. J. L. Herington, K. L. Bruner-Tran, J. A. Lucas, and K. G. Osteen, “Immune interactions in endometriosis,” Expert Review of Clinical Immunology, vol. 7, no. 5, pp. 611–626, 2014.
4. C. M. Kyama, S. Debrock, J. M. Mwenda, and T. M. D'Hooghe, “Potential involvement of the immune system in the development of endometriosis,” Reproductive Biology and Endocrinology, vol. 1, no. 1, p. 123, 2003.
5. G. Matarese, G. De Placido, Y. Nikas, and C. Alviggi, “Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?,” Trends in Molecular Medicine, vol. 9, no. 5, pp. 223–228, 2003.
6. G. Christodoulakos, A. Augoulea, I. Lambrinoudaki, V. Sioulas, and G. Creatsas, “Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’,” The European Journal of Contraception & Reproductive Health Care, vol. 12, no. 3, pp. 194–202, 2009.
7. I. Soave, D. Caserta, J. M. Wenger, S. Dessole, A. Perino, and R. Marci, “Environment and endometriosis: a toxic relationship,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 11, pp. 1964–1972, 2015.
8. T. Roszer, “Understanding the mysterious M2 macrophage through activation markers and effector mechanisms,” Mediators of Inflammation, vol. 2015, Article ID 816460, 16 pages, 2015.
9. N. Wang, H. Liang, and K. Zen, “Molecular mechanisms that influence the macrophage m1-m2 polarization balance,” Frontiers in Immunology, vol. 5, p. 614, 2014.
10. I. Malyshev and Y. Malyshev, “Current concept and update of the macrophage plasticity concept: intracellular mechanisms of reprogramming and M3 macrophage “switch” phenotype,” BioMed Research International, vol. 2015, Article ID 341308, 22 pages, 2015.
11. F. Zhang, H. Wang, X. Wang et al., “TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype,” Oncotarget, vol. 7, no. 32, pp. 52294–52306, 2016.
12. D. Gong, W. Shi, S. J. Yi, H. Chen, J. Groffen, and N. Heisterkamp, “TGFβ signaling plays a critical role in promoting alternative macrophage activation,” BMC Immunology, vol. 13, no. 1, p. 31, 2012.
13. S. H. Ahn, K. Khalaj, S. L. Young, B. A. Lessey, M. Koti, and C. Tayade, “Immune-inflammation gene signatures in endometriosis patients,” Fertility and Sterility, vol. 106, no. 6, pp. 1420–1431.e7, 2016.
14. S. H. Ahn, S. P. Monsanto, C. Miller, S. S. Singh, R. Thomas, and C. Tayade, “Pathophysiology and immune dysfunction in endometriosis,” BioMed Research International, vol. 2015, Article ID 795976, 12 pages, 2015.
15. K. N. Khan, M. Kitajima, K. Hiraki et al., “Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis,” Fertility and Sterility, vol. 94, no. 7, pp. 2860–2863.e3, 2010.
16. M. Bacci, A. Capobianco, A. Monno et al., “Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease,” The American Journal of Pathology, vol. 175, no. 2, pp. 547–556, 2009.
17. W. Q. Zhong, G. Chen, W. Zhang et al., “M2-polarized macrophages in keratocystic odontogenic tumor: relation to tumor angiogenesis,” Scientific Reports, vol. 5, no. 1, p. 15586, 2015.
18. J. Zhou, J. O. Jin, E. S. Patel, and Q. Yu, “Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditions,” Cytokine, vol. 76, no. 2, pp. 244–252, 2015.
19. C. S. Ku, T. X. Pham, Y. Park et al., “Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes,” Bio-chimica et Biophysica Acta (BBA) - General Subjects, vol. 1830, no. 4, pp. 2981–2988, 2013.
20. E. Sierra-Filardi, A. Puig-Kroger, F. J. Blanco et al., “Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers,” Blood, vol. 117, no. 19, pp. 5092–5101, 2011.
21. F. Itoh, Y. Komohara, K. Takaishi et al., “Possible involvement of signal transducer and activator of transcription-3 in cell-cell interactions of peritoneal macrophages and endometrial stromal cells in human endometriosis,” Fertility and Sterility, vol. 99, no. 6, pp. 1705–1713.e1, 2013.
22. J. Mei, X. X. Xie, M. Q. Li et al., “Indoleamine 2,3-dioxygenase-1 (IDO1) in human endometrial stromal cells induces macrophage tolerance through interleukin-33 in the progression of endometriosis,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 6, pp. 2743–2757, 2014.
23. A. Capobianco and P. Rovere-Querini, “Endometriosis, a disease of the macrophage,” Frontiers in Immunology, vol. 4, 2013.
24. A. Pizzo, F. M. Salmeri, F. V. Ardita, V. Sofo, M. Tripepi, and S. Marsico, “Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis,” Gynecologic and Obstetric Investigation, vol. 54, no. 2, pp. 82–87, 2003.
25. J. L. Suen, Y. Chang, P. R. Chiu et al., “Serum level of IL-10 is increased in patients with endometriosis, and IL-10 promotes the growth of lesions in a murine model,” The American Journal of Pathology, vol. 184, no. 2, pp. 464–471, 2014.
26. B. F. Chong, L. C. Tseng, G. A. Hosler et al., “A subset of CD163+ macrophages displays mixed polarizations in discoid lupus skin,” Arthritis Research & Therapy, vol. 17, no. 1, p. 324, 2015.
27. E. Kalu, N. Sumar, T. Giannopoulos et al., “Cytokine profiles in serum and peritoneal fluid from infertile women with and without endometriosis,” Journal of Obstetrics and Gynaecology Research, vol. 33, no. 4, pp. 490–495, 2007.
28. S. Li, X. Fu, T. Wu, L. Yang, C. Hu, and R. Wu, “Role of interleukin-6 and its receptor in endometriosis,” Medical Science Monitor, vol. 23, pp. 3801–3807, 2017.
29. T. Tsudo, T. Harada, T. Iwabe et al., “Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues,” Fertility and Sterility, vol. 73, no. 2, pp. 205–211, 2000.
30. K. A. Burns, S. Y. Thomas, K. J. Hamilton, S. L. Young, D. N. Cook, and K. S. Korach, “Early endometriosis in females is directed by immune-mediated estrogen receptor α and IL-6 cross-talk,” Endocrinology, vol. 159, no. 1, pp. 103–118, 2018.